Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier

被引:22
作者
Ampasavate, C [1 ]
Chandorkar, GA [1 ]
Vander Velde, DG [1 ]
Stobaugh, JF [1 ]
Audus, KL [1 ]
机构
[1] Univ Kansas, Dept Pharmaceut Chem, Simons Labs, Lawrence, KS 66047 USA
关键词
placenta; permeability; metabolism; BeWo; opioid peptides;
D O I
10.1016/S0378-5173(01)00929-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In keeping with the advance of biotechnology, cell culture becomes an important tool for investigating the transport and the metabolism phenomena. A cell line of human origin, the BeWo choriocarcinoma cell line, was used for the study of the transport and metabolism of opioid peptides across the in vitro model of the placental barrier. Opioid peptides, both naturally occurring and their synthetic analogs, are of interest to be developed as potent analgesics and were included in this study. The apparent permeability coefficients (P-e)s of the peptides containing 4-11 amino acid or analog residues were in the range of 0.23-14.6 x 10(-5) cm/s. The (P-e)s of these peptides were comparable to those of sucrose or dextrans, hydrophilic markers. The (P-e)s of low molecular weight (MW) peptides was not dependent on their MW or molecular size, whereas an inversely linear correlation between (P-e)s and molecular size was observed with the larger peptides. Molecular sieving of the BeWo monolayer restricted the transport of the peptides with MW greater than or equal to 1033 Da or molecular size greater than or equal to 6.6 Angstrom. Membrane partitioning ability and charge of the peptides were also investigated and found to be the minor factors regulating the extent of peptide permeation. Contrasting to the transport of Tyr-[D-pen-Gly-Phe-D-Pen] (DPDPE) peptide analog across the blood-brain barrier, the transport of DPDPE across the BeWo monolayers were not indicated to be via carrier-mediated transport. The major transport pathway of the opioid peptides across the BeWo monolayers was found to,be via paracellular route. In metabolism studies, aminopeptidase was found to be a major enzyme type responsible for the degradation of naturally occurring peptides but not for the synthetic analogs. The finding obtained from the present study reveals the applicability of the BeWo cell line as an in vitro model for investigating placental transport and metabolism of opioid peptides. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:85 / 98
页数:14
相关论文
共 36 条
  • [1] QUANTITATIVE APPROACHES TO DELINEATE PARACELLULAR DIFFUSION IN CULTURED EPITHELIAL-CELL MONOLAYERS
    ADSON, A
    RAUB, TJ
    BURTON, PS
    BARSUHN, CL
    HILGERS, AR
    AUDUS, KL
    HO, NFH
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (11) : 1529 - 1536
  • [2] AUDUS KL, 1998, PEPTIDE PROTEIN DRUG, P67
  • [3] pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs
    Avdeef, A
    Box, KJ
    Comer, JEA
    Hibbert, C
    Tam, KY
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (02) : 209 - 215
  • [4] Chromatographic indexes on immobilized artificial membranes for local anesthetics: Relationships with activity data on closed sodium channels
    Barbato, F
    La Rotonda, MI
    Quaglia, F
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (12) : 1699 - 1705
  • [5] MOLECULAR CHARGE EFFECTS ON THE PROTEIN PERMEABILITY OF THE GUINEA-PIG PLACENTA
    BERHE, A
    BARDSLEY, WG
    HARKES, A
    SIBLEY, CP
    [J]. PLACENTA, 1987, 8 (04) : 365 - 380
  • [6] RETENTION MECHANISM FOR REVERSED-PHASE ION-PAIR LIQUID-CHROMATOGRAPHY
    BIDLINGMEYER, BA
    DEMING, SN
    PRICE, WP
    SACHOK, B
    PETRUSEK, M
    [J]. JOURNAL OF CHROMATOGRAPHY, 1979, 186 (DEC): : 419 - 434
  • [7] Peptide transport and metabolism across the placenta
    Chandorkar, GA
    Ampasavate, C
    Stobaugh, JF
    Audus, KL
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 38 (01) : 59 - 67
  • [8] Superfused microcarrier cultures of choriocarcinoma cells: A dynamic model for studying transport of glucose and amino acids
    Eaton, BM
    Sooranna, SR
    [J]. PLACENTA, 1996, 17 (04) : 209 - 215
  • [9] GALLIGAN JJ, 1984, J PHARMACOL EXP THER, V229, P641
  • [10] Greene DL, 1996, J PHARMACOL EXP THER, V277, P1366